Search

Aditi Dutt

Examiner (ID: 15807, Phone: (571)272-9037 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1649, 1675
Total Applications
622
Issued Applications
221
Pending Applications
78
Abandoned Applications
328

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5666578 [patent_doc_number] => 20060171928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Monocyte-origin multipotent cell momc' [patent_app_type] => utility [patent_app_number] => 10/549707 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11886 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171928.pdf [firstpage_image] =>[orig_patent_app_number] => 10549707 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/549707
Monocyte-origin multipotent cell MOMC Mar 17, 2004 Issued
Array ( [id] => 4921949 [patent_doc_number] => 20080070264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes' [patent_app_type] => utility [patent_app_number] => 10/548147 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15194 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070264.pdf [firstpage_image] =>[orig_patent_app_number] => 10548147 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/548147
Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes Mar 4, 2004 Abandoned
Array ( [id] => 7677168 [patent_doc_number] => 20040152658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Immediate early genes and methods of use therefor' [patent_app_type] => new [patent_app_number] => 10/792481 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24625 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152658.pdf [firstpage_image] =>[orig_patent_app_number] => 10792481 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/792481
Immediate early genes and methods of use therefor Mar 1, 2004 Abandoned
Array ( [id] => 7276282 [patent_doc_number] => 20040235733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods and reagents for reducing polyglutamine toxicity' [patent_app_type] => new [patent_app_number] => 10/789518 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13679 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235733.pdf [firstpage_image] =>[orig_patent_app_number] => 10789518 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/789518
Methods and reagents for reducing polyglutamine toxicity Feb 26, 2004 Abandoned
Array ( [id] => 7313040 [patent_doc_number] => 20040143859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Novel proteins and methods for producing the proteins' [patent_app_type] => new [patent_app_number] => 10/785114 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21176 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143859.pdf [firstpage_image] =>[orig_patent_app_number] => 10785114 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/785114
Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein Feb 24, 2004 Issued
Array ( [id] => 5872956 [patent_doc_number] => 20060165696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Remedy for spinal injury containing interleukin-6 antagonist' [patent_app_type] => utility [patent_app_number] => 10/546149 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12780 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165696.pdf [firstpage_image] =>[orig_patent_app_number] => 10546149 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546149
Remedy for spinal injury containing interleukin-6 antagonist Feb 23, 2004 Abandoned
Array ( [id] => 5732288 [patent_doc_number] => 20060257405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr)' [patent_app_type] => utility [patent_app_number] => 10/545454 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32863 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257405.pdf [firstpage_image] =>[orig_patent_app_number] => 10545454 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545454
Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr) Feb 12, 2004 Abandoned
Array ( [id] => 5734874 [patent_doc_number] => 20060259991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases' [patent_app_type] => utility [patent_app_number] => 10/543314 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14361 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20060259991.pdf [firstpage_image] =>[orig_patent_app_number] => 10543314 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/543314
Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases Feb 1, 2004 Abandoned
Array ( [id] => 5844320 [patent_doc_number] => 20060122111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Regeneration and neogenesis of retinal visual cell otx2 gene' [patent_app_type] => utility [patent_app_number] => 10/542248 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15883 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122111.pdf [firstpage_image] =>[orig_patent_app_number] => 10542248 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/542248
Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein Feb 1, 2004 Issued
Array ( [id] => 7424485 [patent_doc_number] => 20040208862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Neuronal regeneration' [patent_app_type] => new [patent_app_number] => 10/754102 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33401 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208862.pdf [firstpage_image] =>[orig_patent_app_number] => 10754102 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/754102
Neuronal regeneration Jan 6, 2004 Issued
Array ( [id] => 5209985 [patent_doc_number] => 20070248569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization' [patent_app_type] => utility [patent_app_number] => 10/541492 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9657 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248569.pdf [firstpage_image] =>[orig_patent_app_number] => 10541492 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/541492
Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization Jan 5, 2004 Abandoned
Array ( [id] => 7351206 [patent_doc_number] => 20040248795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Membrane-permeable peptide capable of calpain inhibition' [patent_app_type] => new [patent_app_number] => 10/751658 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3225 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248795.pdf [firstpage_image] =>[orig_patent_app_number] => 10751658 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/751658
Membrane-permeable peptide capable of calpain inhibition Jan 5, 2004 Issued
Array ( [id] => 5674137 [patent_doc_number] => 20060179492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating' [patent_app_type] => utility [patent_app_number] => 10/538245 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12820 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20060179492.pdf [firstpage_image] =>[orig_patent_app_number] => 10538245 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/538245
Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating Dec 7, 2003 Abandoned
Array ( [id] => 5844318 [patent_doc_number] => 20060122110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/537757 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 46146 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122110.pdf [firstpage_image] =>[orig_patent_app_number] => 10537757 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/537757
Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system Dec 4, 2003 Abandoned
Array ( [id] => 5760664 [patent_doc_number] => 20060211609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Novel agent for improving neurotransmission failure' [patent_app_type] => utility [patent_app_number] => 10/536963 [patent_app_country] => US [patent_app_date] => 2003-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5682 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211609.pdf [firstpage_image] =>[orig_patent_app_number] => 10536963 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/536963
Novel agent for improving neurotransmission failure Nov 27, 2003 Abandoned
Array ( [id] => 5912309 [patent_doc_number] => 20060127371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells' [patent_app_type] => utility [patent_app_number] => 10/536491 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18476 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127371.pdf [firstpage_image] =>[orig_patent_app_number] => 10536491 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/536491
ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells Nov 24, 2003 Abandoned
Array ( [id] => 7436763 [patent_doc_number] => 20040185113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein' [patent_app_type] => new [patent_app_number] => 10/478344 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4863 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185113.pdf [firstpage_image] =>[orig_patent_app_number] => 10478344 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/478344
Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein Nov 20, 2003 Abandoned
Array ( [id] => 7316702 [patent_doc_number] => 20040223966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'ActRIIB fusion polypeptides and uses therefor' [patent_app_type] => new [patent_app_number] => 10/689677 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14257 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223966.pdf [firstpage_image] =>[orig_patent_app_number] => 10689677 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/689677
ActRIIB fusion polypeptides and uses therefor Oct 21, 2003 Abandoned
Array ( [id] => 5630957 [patent_doc_number] => 20060147425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Use of enteric glia to promote functional nerve connections' [patent_app_type] => utility [patent_app_number] => 10/531425 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8173 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147425.pdf [firstpage_image] =>[orig_patent_app_number] => 10531425 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/531425
Use of enteric glia to promote functional nerve connections Oct 14, 2003 Abandoned
Array ( [id] => 7211558 [patent_doc_number] => 20050054012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Methods of detecting and treating facioscapulohumeral muscular dystrophy' [patent_app_type] => utility [patent_app_number] => 10/686491 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16902 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054012.pdf [firstpage_image] =>[orig_patent_app_number] => 10686491 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/686491
Methods of detecting and treating facioscapulohumeral muscular dystrophy Oct 13, 2003 Abandoned
Menu